Consistently, serum levels of HDL-apoA-II and HDL3-apoA-II were lower in more severe AHF cases, such as those with venous congestion, MetS, or AF, than those without, as well as in the patients who developed AHF on top of CHF, compared with the new-onset AHF cases [48]. The gene discussed is APOA2; the disease is metabolic syndrome.